Common Mistakes We See Researchers Make Our team consults with labs all the time, and we've seen a few common, heartbreaking mistakes that lead to failed experiments
Both started as diabetes medications Jardiance and Ozempic were both originally developed to manage type 2 diabetes , not weight loss
A new generation of dual and triple receptor modulators targeting nutrient-stimulated hormone pathways are producing cardiometabolic effects that exceed any previous pharmacotherapy, with weight loss efficacy approaching that of bariatric surgery
This antagonist brings a myriad of health risks to the table, from type 2 diabetes, heart disease, stroke, and certain types of cancer to sleep apnea, osteoarthritis, and mental health issues
This article explains what biomarkers can optionally be monitored on GLP-1 therapy and why, who might benefit from testing versus who likely does not need it, what baseline and ongoing monitoring might involve if you choose to do it, and how to decide what makes sense for your situation